Alnylam Pharmaceuticals (ALNY) Q2 2021 Earnings

29AprConfirmed
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-2.18
-1.97
-1.77
-1.56

Details

Expected EPS
-1.8
Actual EPS
-1.71
Surprise EPS
0.09
Surprise Percent
+5%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.71 per share for Q2 2021.

0 Comments

Share your thoughts